arrow
M

Moh'd Khushman

University System of Ohio
H指数:22
被引数:2,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors

二甲双胍对接受免疫检查点抑制剂治疗的患者中DNA错配修复缺陷和微卫星不稳定性(dMMR/MSI)结直肠癌结局的实时世界影响

2025-12-100
OA
A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN ADAMANTINOMATOUS CRANIOPHARYNGIOMA (ACP) PATIENTS

I期/II期FOG-001试验:一种首创的、直接作用于β-CATENIN:TCF4的抑制剂,在成釉细胞瘤性颅咽管瘤(ACP)患者中的安全性及初步抗肿瘤活性研究

2025-11-010
OAAI
Differential gene expression profiles of pancreatic ductal adenocarcinomas among African American and caucasian American patients

胰腺导管腺癌在非裔美国人和高加索美国患者中的差异基因表达谱

2025-07-080
PRE
Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer
2025-03-120
OAAI
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
2024-07-114
OAAI
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
2023-07-037
OAAI